2005
DOI: 10.1016/j.ijantimicag.2005.08.003
|View full text |Cite
|
Sign up to set email alerts
|

Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

20
127
5
8

Year Published

2009
2009
2018
2018

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 178 publications
(160 citation statements)
references
References 29 publications
20
127
5
8
Order By: Relevance
“…Conversely, we found that trimethoprim-sulfamethoxazole was prescribed consistently throughout the observation period for ϳ50% of UTI antibiotic visits, despite publication of numerous studies demonstrating that resistance rates to this antibiotic range from 20% to 40%. 14,[17][18][19] Broad-spectrum antibiotics were administered in approximately one third of UTI antibiotic visits. Whether this is an example of overprescribing of broad-spectrum antibiotics in the empiric treatment of UTI is difficult to establish.…”
Section: Summary Of Findingsmentioning
confidence: 99%
“…Conversely, we found that trimethoprim-sulfamethoxazole was prescribed consistently throughout the observation period for ϳ50% of UTI antibiotic visits, despite publication of numerous studies demonstrating that resistance rates to this antibiotic range from 20% to 40%. 14,[17][18][19] Broad-spectrum antibiotics were administered in approximately one third of UTI antibiotic visits. Whether this is an example of overprescribing of broad-spectrum antibiotics in the empiric treatment of UTI is difficult to establish.…”
Section: Summary Of Findingsmentioning
confidence: 99%
“…Not surprisingly, the rates of resistance to these antibiotics in UPEC strains have steadily risen over the past few decades. In the United States, Canada, and elsewhere, ∼10-25% of uncomplicated UTI isolates are resistant to TMP-SMX (9)(10)(11). This trend is forcing physicians to reach for more expensive and sometimes less effective drugs to treat UTIs (10,12,13).…”
mentioning
confidence: 99%
“…Our findings are similar to other studies, although the prevalences vary. [9][10][11][12][13] In this research, most cases were complicated UTIs (72.8%), which was related to two factors, male gender (28.1%) and diabetes mellitus (25.9%). This research was performed in a tertiary care center where there was high pathogenic resistance, at 80.9% for ampicillin, 33.9% for ceftriaxone, 50.0% for norfloxacin, and 48.5% to cotrimoxazole, our first line drug, but all the pathogens studied were more than 70.0% susceptible to fosfomycin and nitrofurantoin so this research suggests treating UTIs with these agents.…”
Section: Discussionmentioning
confidence: 58%